Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Arq, Inc. (ARQ) Reports Q4 Loss, Misses Revenue Estimates

Arq, Inc. (ARQ) Reports Q4 Loss, Misses Revenue Estimates

FinvizFinviz2026/03/10 00:57
By:Finviz

Arq, Inc. (ARQ) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.03 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of -55.56%. A quarter ago, it was expected that this company would post earnings of $0.02 per share when it actually produced a loss of $0.02, delivering a surprise of -200%.

Over the last four quarters, the company has surpassed consensus EPS estimates just once.

Arq, Inc., which belongs to the Zacks Chemical - Specialty industry, posted revenues of $29.43 million for the quarter ended December 2025, missing the Zacks Consensus Estimate by 0.43%. This compares to year-ago revenues of $27.04 million. The company has topped consensus revenue estimates two times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Arq, Inc. shares have lost about 1.8% since the beginning of the year versus the S&P 500's decline of 1.5%.

What's Next for Arq, Inc.?

While Arq, Inc. has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Arq, Inc. was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.06 on $29.5 million in revenues for the coming quarter and -$0.03 on $136.77 million in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Chemical - Specialty is currently in the bottom 43% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

One other stock from the same industry, H. B. Fuller (FUL), is yet to report results for the quarter ended February 2026.

This adhesives company is expected to post quarterly earnings of $0.56 per share in its upcoming report, which represents a year-over-year change of +3.7%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

H. B. Fuller's revenues are expected to be $790.1 million, up 0.2% from the year-ago quarter.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

TRexBio: IPO Of 8.3M Shares Priced at $14.00 Each >TRXB

TRexBio: IPO Of 8.3M Shares Priced at $14.00 Each >TRXB

Dow Jones•2026/10/09 01:47

Talos Energy director Barbara J. Faulkenberry files initial beneficial ownership statement

Talos Energy director Barbara J. Faulkenberry filed an initial Form 3 statement dated Oct. 1, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Talos Energy Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-418248), on October 08, 2026, and is solely responsible for the information contained therein.

Bitget•2026/10/09 01:05

Exchange Traded Funds Top 10 Volume Leaders

NET % VOL STOCK (Symbol) LAST CHG CHG 100s Direxion Semicon Br 3x SOXS 33.79 3.14 10.24 113,576,607 ProShares Bitcoin ETF BITO 10.93 -0.21 -1.89 112,012,221 Direxion Semicon Bl 3x SOXL 142.52 -16.39 -10.31 100,351,229 ProShares Sh Russell2001 RWM 14.43 0.01 0.07 77,482,048 GrShr 2x Sh NVDA Daily NVD 3.55 0.20 5.97 73,813,301 ProShares UltraPro QQQ TQQQ 80.23 -3.39 -4.05 65,485,124 ProSh UltraPro Shrt QQQ SQQQ 33.37 1.30 4.05 60,470,210 iShares Bitcoin Trust ETF IBIT 46.26 -0.95 -2.01 56,191,237 Direxion PLTR Bear 1X PLTD 4.50 -0.11 -2.39 52,552,250 SS Energy Sel SPDR XLE 65.24 1.88 2.97 50,492,628 (END) Dow Jones Newswires October 08, 2026 17:38 ET (21:38 GMT)

Dow Jones•2026/10/08 21:38